Inventor · disambiguated record
Laureano Simón Buela
Also filed as: BUELA LAUREANO SIMON · BUELA LAUREANO SIMÓN
4 granted patents·5 pending applications·9 citations·filing 2004–2020
66Inventor score
Files withPATIA BIOPHARMA S A DE C V2PROGENIKA BIOPHARMA SA2ILLARRAMENDI AINARA VALLEJO1MARTINEZ MARTINEZ ANTONIO1ONCOMATRIX S L1
Top patents by PatentIndex Score
9 records- 0168US7914990B2Methods and products for in vitro genotypingPROGENIKA BIOPHARMA SA·Filed 2006·Granted Mar 29, 2011·5 cites·11 claims
- 0261US11085082B2Methods, tools and systems for the prediction and assessment of gestational diabetesPATIA BIOPHARMA S A DE C V·Filed 2016·Granted Aug 10, 2021·1 cites·9 claims
- 0356US2008274968A1In vitro methods for detecting renal cancerPROGENIKA BIOPHARMA SA·Filed 2008·Application pending·0 cites
- 0451US2008015143A1In Vitro Methods for Detecting Renal CancerROMAN JOSE JAVIER GOMEZ·Filed 2004·Application pending·0 cites
- 0548US11578368B2Methods, tools and systems for the assessment, prevention, management and treatment selection for type 2 diabetesPATIA BIOPHARMA S A DE C V·Filed 2020·Granted Feb 14, 2023·0 cites·10 claims
- 0648US8124331B2In vitro method to detect bladder transitional cell carcinomaMARTINEZ MARTINEZ ANTONIO·Filed 2004·Granted Feb 28, 2012·3 cites·20 claims
- 0741US2016274119A1Methods and products for the diagnosis and prognosis of ovarian tumor malignancyONCOMATRIX S L·Filed 2014·Application pending·0 cites
- 0840US2018094318A1Methods, tools and systems for the assessment, prevention, management and treatment selection for type 2 diabetesPATIA BIOPHARMIA S A DE C V·Filed 2016·Application pending·0 cites
- 0930US2008113347A1Method for the in Vitro Diagnosis and Prognosis of Demyelinating Diseases, and for the Development of Drugs Against Demyelinating DiseasesILLARRAMENDI AINARA VALLEJO·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laureano Simón Buela files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →